Pulmonary inflammatory myofibroblastic tumor versus IgG4-related inflammatory pseudotumor: differential diagnosis based on a case series

被引:21
|
作者
Zhu, Longfei [1 ]
Li, Jian [1 ]
Liu, Chengwu [1 ]
Ding, Wenshuang [2 ]
Lin, Feng [1 ]
Guo, Chenglin [1 ]
Liu, Lunxu [1 ]
机构
[1] Sichuan Univ, Dept Thorac Surg, West China Hosp, Chengdu 610041, Peoples R China
[2] Sichuan Univ, West China Hosp, Dept Pathol, Chengdu 610041, Peoples R China
关键词
Inflammatory myofibroblastic tumor (IMT); inflammatory pseudotumor (IPT); differential diagnosis; PLASMA-CELL GRANULOMA; ALK; GENE; LUNG; REARRANGEMENT; EXPRESSION; FUSION; 2P23;
D O I
10.21037/jtd.2017.02.89
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Pulmonary inflammatory myofibroblastic tumor (IMT) has been considered as a synonym for inflammatory pseudotumor (IPT) for a long time. Recent studies have indicated that IMT and I(g)G4-related IPT are distinct diseases. However, no consensus criteria have been recommended. Here we propose a set of criteria for the differential diagnosis. Methods: Twenty-six archived IMT and I(g)G4-related IPT samples were examined for histological characteristics and the expression of I(g)G, I(g)G4, SMA and ALK-1. Based on our proposed criteria, we reclassified the cases into either IMT or IgG4-related IPT group and compared the clinicopathological features, laboratory findings, overall survivals (OS) and disease-free survivals between groups to validate the effectiveness and dependability of the diagnostic criteria. Results: The average age of IgG4-related IPT group was higher than IMTs (48.82 vs. 39.22 years, P= 0.031). In IMT group, tumors were characterized by bigger tumor sizes (3.47 vs. 2.22 cm, P= 0.007), diffuse and total destroyed alveoli (88.89% vs. 17.65%, P= 0.002), fewer lymphoid follicles (1.6/ HPF vs. 3.0/ HPF, P= 0.045) and lower expression of IgG (74.7/ HPF vs. 149.1/ HPF; P < 0.001). As an exclusion criterion of IgG4-related IPT, ALK-positivity was correlated with the higher cytological atypia (mean 3.7/ HPF, P < 0.001) and lesser lymphoid follicles (mean 1.2/ HPF, P= 0.021). And it's the first study to show the liner positive correlation between the lymphocytes + plasma cells count and IgG4-positive plasma cells count in these lesions (r= 0.914, P < 0.001). The negative correlation between the IgG4-positive plasma cells count and the expression of ALK-1 are reported for the first time as well (rs=-0.632, P= 0.001). However, despite two patients with recurrence or metastasis were divided into IMT group, only borderline values were detected in the survival analysis (OS 88.89% vs. 100%, P= 0.197, DFS 77.78% vs. 100.00%; P= 0.056). Conclusions: The significant differences of clinicopathological characteristics between the IMTs and I(g)G4-related IPTs indicated that a combination of lymphocytes + plasma cells count, cytological atypia, IgG4 and ALK-1 staining will be helpful in differential diagnosis.
引用
收藏
页码:598 / 609
页数:12
相关论文
共 50 条
  • [1] Pulmonary inflammatory myofibroblastic tumor and IgG4-related inflammatory pseudotumor: a diagnostic dilemma
    Bhagat, Priyanka
    Bal, Amanjit
    Das, Ashim
    Singh, Navneet
    Singh, Harkant
    VIRCHOWS ARCHIV, 2013, 463 (06) : 743 - 747
  • [2] Inflammatory Myofibroblastic Tumor Versus IgG4-related Sclerosing Disease and Inflammatory Pseudotumor A Comparative Clinicopathologic Study
    Yamamoto, Hidetaka
    Yamaguchi, Hiroshi
    Aishima, Shinichi
    Oda, Yoshinao
    Kohashi, Kenichi
    Oshiro, Yumi
    Tsuneyoshi, Masazumi
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2009, 33 (09) : 1330 - 1340
  • [3] Pulmonary inflammatory myofibroblastic tumor and IgG4-related inflammatory pseudotumor: a diagnostic dilemma
    Priyanka Bhagat
    Amanjit Bal
    Ashim Das
    Navneet Singh
    Harkant Singh
    Virchows Archiv, 2013, 463 : 743 - 747
  • [4] IgG4-related inflammatory pseudotumor of the ileal conduit
    Kuroda, Yoko
    Fujioka, Masashi
    Kurosawa, Kazuhiro
    Ohashi, Kenichi
    PATHOLOGY INTERNATIONAL, 2011, 61 (01) : 47 - 48
  • [5] Inflammatory myofibroblastic tumor (inflammatory pseudotumor) of the breast - Case report
    Ilvan, S
    Celik, V
    Paksoy, M
    Cetinaslan, I
    Calay, Z
    APMIS, 2005, 113 (01) : 66 - 69
  • [6] IgG4 plasma cells in inflammatory myofibroblastic tumor: inflammatory marker or pathogenic link?
    Saab, Shahrazadb T.
    Hornick, Jason L.
    Fletcher, Christopher D.
    Olson, Sandra J.
    Coffin, Cheryl M.
    MODERN PATHOLOGY, 2011, 24 (04) : 606 - 612
  • [7] IgG4-related inflammatory pseudotumor: A systematic review of histopathological features of reported cases
    Chougule, Abhijit
    Bal, Amanjit
    MODERN RHEUMATOLOGY, 2017, 27 (02) : 320 - 325
  • [8] Pulmonary Inflammatory Myofibroblastic Tumor: A Case Report
    Bruyninckx, Lotte
    De Leyn, Paul
    Van Raemdonck, Dirk
    Jansen, Yanina
    Coppens, Katrien
    Vermeulen, Francois
    Weynand, Birgit
    Gieraerts, Christopher
    Decaluwe, Herbert
    EUROPEAN JOURNAL OF PEDIATRIC SURGERY REPORTS, 2024, 12 (01) : e73 - e76
  • [9] Pathological classification of hepatic inflammatory pseudotumor with respect to IgG4-related disease
    Zen, Yoh
    Fujii, Takahiko
    Sato, Yasunori
    Masuda, Shinji
    Nakanuma, Yasuni
    MODERN PATHOLOGY, 2007, 20 (08) : 884 - 894
  • [10] Morphologic Overlap Between Inflammatory Myofibroblastic Tumor and IgG4-related Disease Lessons From Next-generation Sequencing
    Taylor, Martin S.
    Chougule, Abhijit
    MacLeay, Allsion R.
    Kurzawa, Pawel
    Chebib, Ivan
    Le, Long
    Deshpande, Vikram
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2019, 43 (03) : 314 - 324